INTRA-CELLULAR THERAPIES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 73.26 USD | +1.57% |
|
+1.23% | +2.29% |
Chart calendar Intra-Cellular Therapies, Inc.
f646a750b82b443858769.NDj43PIYvTJSNgkHyFZ_bzyks7D50VlerXcToOsU-_I.dmGvssN97Eg9Q0prqx01OnOd4N62hCkG1URb8ZwhtppGT7TpijXZBH9ufg~a0fa6b10d66fe428f07cdf717500b95b
Upcoming events on Intra-Cellular Therapies, Inc.
Past events on Intra-Cellular Therapies, Inc.
| 16/04/2024 06:00 pm | MDD Study 501 Topline Results Call |
| 18/03/2024 | UBS Virtual CNS Day |
| 13/03/2024 | Jefferies Biotech on the Bay Summit |
| 12/03/2024 08:10 pm | Leerink Partners Global Biopharma Conference |
| 05/03/2024 09:40 pm | TD Cowen Health Care Conference |
| 22/02/2024 07:00 pm | Q4 2023 Earnings Call |
| 22/02/2024 06:00 pm | Q4 2023 Earnings Release |
| 09/01/2024 09:45 pm | JPMorgan Healthcare Conference |
| 04/12/2023 | American College of Neuropsychopharmacology Meeting - Poster No: M88 |
| 04/12/2023 | American College of Neuropsychopharmacology Meeting - Poster No: M131 |
| 04/12/2023 | American College of Neuropsychopharmacology Meeting - Poster No:M91 |
| 29/11/2023 01:55 am | Evercore ISI HealthCONx Conference |
| 08/11/2023 09:30 pm | UBS BioPharma Conference - Fireside Chat |
| 06/11/2023 | J.P. Morgan Equity Opportunities Forum |
| 02/11/2023 06:00 pm | Q3 2023 Earnings Call |
| 02/11/2023 05:00 pm | Q3 2023 Earnings Release |
| 27/09/2023 10:45 pm | Cantor Global Healthcare Conference |
| 12/09/2023 10:25 pm | Morgan Stanley Global Healthcare Conference |
| 06/09/2023 | Psych Congress - Poster Number - 152 |
| 06/09/2023 | Psych Congress - Poster Number - 132 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,06 0,00 - | 22,8 22,3 2.48% | 83,8 83,1 0.84% | 250 249 0.38% | 464 468 -0.81% | 662 |
|
EBITDA Million USD | Released Forecast Spread | -154 -155 0.68% | -231 -240 4.01% | -285 -284 -0.44% | -263 -276 4.73% | -159 -173 8.37% | -80,7 |
|
EBIT Million USD | Released Forecast Spread | -154 -159 3.26% | -231 -237 2.62% | -286 -282 -1.31% | -264 -274 3.7% | -159 -172 7.53% | -81,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -148 -152 2.7% | -227 -236 3.77% | -284 -282 -0.7% | -256 -271 5.52% | -139 -154 9.86% | -61,6 |
|
Net income Million USD | Released Forecast Spread | -148 -151 2.49% | -227 -234 2.88% | -284 -282 -0.74% | -256 -270 5.14% | -140 -155 10.02% | -59,5 |
|
EPS USD | Released Forecast Spread | -2,68 -2,74 2.29% | -3,23 -3,34 3.29% | -3,50 -3,45 -1.33% | -2,72 -2,87 5.09% | -1,46 -1,63 10.25% | -0,63 |
| Announcement Date | 02/03/20 | 25/02/21 | 01/03/22 | 01/03/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 25,7 25,0 2.65% | 35,0 33,5 4.42% | 55,6 48,6 14.3% | 71,9 66,0 8.89% | 87,9 87,0 1.04% | 95,3 92,4 3.13% | 111 107 3.72% | 126 119 5.83% | 132 136 -2.63% | 141 | 159 | 172 | 187 | 184 |
|
EBITDA Million USD | Released Forecast Spread | -85,9 -87,8 2.21% | -72,5 -85,3 15% | -87,8 -78,3 -12.14% | -55,5 -83,9 33.92% | -47,3 -71,0 33.42% | -48,3 -67,5 28.46% | -47,1 -57,2 17.75% | -29,6 -65,1 54.53% | -34,0 -50,7 32.99% | -35,5 | -26,6 | -19,2 | -6,05 | |
|
EBIT Million USD | Released Forecast Spread | -86,0 -82,3 -4.53% | -72,7 -84,0 13.45% | -87,9 -70,7 -24.33% | -55,6 -77,3 28.06% | -47,4 -57,3 17.29% | -48,4 -60,1 19.5% | -47,2 -57,8 18.39% | -29,7 -58,1 48.89% | -34,1 -47,4 28.04% | -34,4 | -23,9 | -17,5 | -9,58 | -25,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -85,7 -83,8 -2.28% | -72,1 -88,7 18.74% | -86,6 -73,8 -17.35% | -53,5 -82,9 35.48% | -44,0 -58,4 24.66% | -44,0 -58,6 24.86% | -42,6 -55,5 23.16% | -24,2 -55,5 56.38% | -28,1 -42,1 33.19% | -30,4 | -19,6 | -12,5 | -0,66 | -20,4 |
|
Net income Million USD | Released Forecast Spread | -85,7 -83,4 -2.79% | -72,1 -85,8 15.93% | -86,6 -72,6 -19.23% | -53,5 -77,3 30.74% | -44,0 -57,5 23.39% | -44,1 -60,0 26.55% | -42,8 -56,5 24.3% | -24,3 -56,5 57.04% | -28,6 -42,5 32.68% | -31,9 | -20,8 | -11,4 | 0,33 | -20,4 |
|
EPS USD | Released Forecast Spread | -1,05 -1,00 -4.64% | -0,78 -0,93 15.95% | -0,92 -0,77 -19.43% | -0,57 -0,82 30.5% | -0,45 -0,60 25.24% | -0,46 -0,62 26.33% | -0,45 -0,59 23.89% | -0,25 -0,59 57.32% | -0,30 -0,45 33.67% | -0,33 | -0,21 | -0,11 | 0,00 | -0,20 |
| Announcement Date | 01/03/22 | 10/05/22 | 09/08/22 | 03/11/22 | 01/03/23 | 04/05/23 | 03/08/23 | 02/11/23 | 22/02/24 | - | - | - | - | - |
More events
Past sector events for Intra-Cellular Therapies, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ITCI Stock
- Calendar Intra-Cellular Therapies, Inc.
